证券代码：300326 证券简称：凯利泰 公告编号：2025-086 上海凯利泰医疗科技股份有限公司 第六届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 上海凯利泰医疗科技股份有限公司（以下简称"公司"）于 2025 年 8 月 19 日 以邮件方式向公司各董事发出关于召开第六届董事会第十次会议的通知，并于 会会议应出席的董事 7 名，实际出席会议的董事 7 名，其中惠一微、WEN CHEN （陈文）、金诗强、朱丁敏、刘学文、狄朝平以通讯表决方式出席会议。会议由 董事长王冲先生主持，公司全部高级管理人员列席会议。本次会议的召集、召开 符合《中华人民共和国公司法》和《上海凯利泰医疗科技股份有限公司章程》的 规定。 二、董事会会议审议情况 经审核，董事会认为公司《2025 年半年度报告》及摘要内容真实、准确、 完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 本议案已经第六届董事会审计委员会第三次会议审议通过。 表决结果：本议案以 7 票同意、0 票反对、0 票弃权、0 票回避获得通过。 ...

Group 1 - The fourth meeting of the board of directors of Meirui New Materials Co., Ltd. was held on August 23, 2025, with all seven directors present, confirming the legality and validity of the meeting [2][3] - The board approved the proposal for capital increase to Meirui Technology to enhance its financial strength and alleviate liquidity pressure, aligning with the company's strategic development plan [4] - The capital increase will result in an increased shareholding ratio for the company in Meirui Technology, which remains a consolidated subsidiary, and will not significantly impact the company's operational and financial status [4]

Group 1 - The company held its 22nd meeting of the 5th Board of Directors on August 22, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1] - The Board unanimously approved the full text and summary of the 2025 semi-annual report, confirming that it accurately reflects the company's financial status and operational conditions without any false statements or omissions [1][2] - The financial report section was reviewed and approved by the company's Audit Committee in its third meeting of 2025 [2] Group 2 - The Board also unanimously approved the special report on the storage and usage of raised funds for the first half of 2025, confirming compliance with relevant laws and regulations without any significant issues [2] - The Board agreed on the provision for asset impairment, stating that it aligns with accounting standards and reflects the company's actual situation, enhancing the fairness of the financial statements [2]

证券代码：301509 证券简称：金凯生科 公告编号：2025-022 金凯（辽宁）生命科技股份有限公司 表决结果：同意票7票，反对票0票，弃权票0票。 第二届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、董事会会议审议情况 一、董事会会议召开情况 董事会经审议认为：公司《2025年半年度报告》及其摘要的编制程序、格式及 内容符合相关法律、法规的规定，真实、准确、完整地反映了报告期内公司的财务 状况和经营成果，不存在任何虚假记载、误导性陈述或者重大遗漏。 金凯（辽宁）生命科技股份有限公司（以下简称"公司"）第二届董事会第八 次会议于2025年8月22日上午9时30分在公司会议室以现场会议结合通讯方式召开。 本次会议通知于2025年8月12日以当面送达结合邮件方式发出。在保障所有董事充 分表达意见的情况下，本次会议采用现场结合通讯方式进行表决，会议应到董事7 人，实到董事7人，其中董事LIANPING WU（吴连萍）、董事宋学章以通讯方式出席。 本次会议由董事长FUMIN WANG（王富民）先生主持，公司监事、高级管理人员、保 荐 ...

证券代码：601588 证券简称：北辰实业 公告编号：临 2025-034 债券代码：188461 债券简称：21 北辰 G1 债券代码：185114 债券简称：21 北辰 G2 债券代码：185738 债券简称：22 北辰 G1 债券代码：254174 债券简称：24 北辰 F1 债券代码：258224 债券简称：25 北辰 F1 债券代码：258483 债券简称：25 北辰 F2 北京北辰实业股份有限公司 第十届第三十七次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 北京北辰实业股份有限公司（以下简称"本公司" ）第十届董事会 第三十七次会议于 2025 年 8 月 22 日（星期五）上午 10:00 于北京市朝 阳区北辰东路 8 号汇园公寓 H 座 2 层第一会议室以现场结合通讯的方 式召开。本次会议应出席董事 8 名，实到董事 7 名，执行董事杨华森 先生委托执行董事梁捷女士代为出席并表决，独立非执行董事甘培忠、 周永健以通讯方式出席并进行表决。会议由本公司董事长张杰先生主 持，本公司部分高级管理人员 ...

证券代码：301208 证券简称：中亦科技 公告编号：2025-023 一、董事会会议召开情况 北京中亦安图科技股份有限公司（以下简称"公司"）第五届董事会第七次 会议通知已于 2025 年 8 月 11 日以邮件方式向全体董事发出，并于 2025 年 8 月 际出席董事 8 人，其中徐晓飞、穆林娟、郑云端、赵龙凯以通讯方式出席本次会 议。本次会议由董事长李东平先生主持，公司高级管理人员列席了会议。本次会 议的召开和表决程序符合《公司法》等法律法规和《公司章程》的规定。 二、董事会会议审议情况 经与会董事认真审议，充分讨论，审慎表决，会议审议并通过了如下议案： 北京中亦安图科技股份有限公司 第五届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或者重大遗漏。 （一）审议通过《关于 <北京中亦安图科技股份有限公司 ensp="ensp" 年半年度报="年半年度报"> 告>全文及其摘要的议案》 根据《深圳证券交易所创业板股票上市规则》等相关规定和要求，公司董事 会编制了《北京中亦安图科技股份有限公司 2025 年半年度报告》及《北京中亦 安图科技股份有 ...

Core Viewpoint - The Gansu Dunhuang Seed Industry Group Co., Ltd. held its 15th temporary meeting of the 9th Board of Directors, where several key resolutions were passed, including the approval of the 2025 semi-annual report and the increase of expected daily related transaction limits [1][2][3] Group 1 - The 2025 semi-annual report and summary were approved by the board, with all 9 directors voting in favor [1] - A proposal to increase the expected limits for daily related transactions was approved, with 8 votes in favor and 1 director abstaining from the vote due to a conflict of interest [2] - The board approved the risk continuous assessment report for Jiu Steel Group Financial Co., Ltd., with 8 votes in favor and 1 director abstaining [2] Group 2 - The board approved the establishment of the company's total salary management measures, with all 9 directors voting in favor [3] - A proposal regarding the adjustment of senior management positions was also approved unanimously by the board [3]

Core Points - The board of directors of Wangsu Technology Co., Ltd. held its 27th meeting on August 14, 2025, to review and approve several key proposals related to the company's financial performance and operational activities [1][2]. Financial Performance - The company reported a total operating income of 786.13 million yuan, representing a year-on-year increase of 7.71% [1]. - The net profit attributable to shareholders of the listed company was 372.51 million yuan, showing a year-on-year growth of 25.33% [1]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 261.40 million yuan, reflecting a year-on-year increase of 22.53% [1]. Board Resolutions - The board unanimously approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's financial status and operational results [2]. - A special report on the storage and use of raised funds for the first half of 2025 was also approved [2]. - The board agreed to provide guarantees for its wholly-owned subsidiary, Shanghai Yunshu Technology Co., Ltd., for a loan application to Shanghai Bank, with a total guarantee amount not exceeding 30 million yuan [3]. - The company decided to apply for a credit limit of 30 million yuan from Ningbo Bank, with the credit being renewable within a one-year term [3].

Meeting Overview - The 19th meeting of the 5th Board of Directors of Beijing Kejingyuan Technology Co., Ltd. was held on August 8, 2025, with all 7 directors present [1] - The meeting was convened by Chairman Ge Jing and complied with relevant laws and regulations [1] Resolutions Passed - The Board approved the full text and summary of the 2025 Half-Year Report, confirming that the report accurately reflects the company's operational status without any false statements or omissions [2] - The Board approved the Special Report on the Storage and Use of Raised Funds for the first half of 2025, affirming compliance with regulatory requirements and no misuse of funds [2] - The Board approved the correction of prior accounting errors, ensuring that the revised financial data accurately reflects the company's financial condition and performance [3] - The Board approved the proposal to abolish the Supervisory Board, transferring its powers to the Audit Committee of the Board, and to amend the company's articles of association accordingly [4] - The Board approved the formulation and revision of several governance systems to enhance corporate governance and compliance with the latest regulations [5][6] - The Board agreed to convene the first temporary shareholders' meeting of 2025 on August 25, 2025, to review the proposals requiring shareholder approval [6]

Group 1 - The board of directors of Xinyangfeng Agricultural Technology Co., Ltd. held its 14th meeting of the 9th session on August 7, 2025, with all 9 directors present, ensuring compliance with legal and procedural requirements [1] - The board approved the 2025 semi-annual report and its summary, which accurately reflects the company's operational status for the first half of 2025, with no false statements or omissions [2] - The voting results for the semi-annual report were unanimous, with 9 votes in favor and no votes against or abstentions [2]